Notably, the impact of PTX3 on fibrosarcoma microenvironment results in a decrease of immune/inflammatory components regardless from its cellular source (i.e., grafted tumor cells or endothelium of the host). This evidence concerns the gene PTX3 and fibrosarcoma.